Cytokines, fatigue, and cutaneous erythema in early stage breast cancer patients receiving adjuvant radiation therapy

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  De Sanctis, Vitaliana ^a   Agolli, Linda ^a   Visco, Vincenzo ^a   Monaco, Flavia ^a   Muni, Roberta ^a   Spagnoli, Alessandra ^b   Campanella, Barbara ^a   Valeriani, Maurizio ^a   Minniti, Giuseppe ^a   Osti, Mattia F ^a   Amanti, Claudio ^a   Pellegrini, Patrizia ^a   Brunetti, Serena ^a   Costantini, Anna ^a   Alfò, Marco ^b   Torrisi, Maria Rosaria ^a   Marchetti, Paolo ^a   Enrici, Riccardo Maurizi ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; GAMMA INTERFERON; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; CYTOKINE;

ADULT; AGED; ANEMIA; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; EARLY CANCER; ERYTHEMA; EXTERNAL BEAM RADIOTHERAPY; FATIGUE; FEMALE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; IATROGENIC DISEASE; MALE; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; QUALITY OF LIFE; RADIATION INDUCED FATIGUE; RADIATION INJURY; ADJUVANT THERAPY; BLOOD; BREAST NEOPLASMS; MIDDLE AGED;

ADULT; AGED; BREAST NEOPLASMS; CYTOKINES; ERYTHEMA; FATIGUE; FEMALE; HUMANS; MIDDLE AGED; RADIOTHERAPY, ADJUVANT;

EID: 84899559047     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/523568     Document Type: Article

References (37)

1. Andrykowski M. A., Schmidt J. E., Salsman J. M., Beacham A. O., Jacobsen P. B., Use of a case definition approach to identify cancer-related fatigue in women undergoing adjuvant therapy for breast cancer. Journal of Clinical Oncology 2005 23 27 6613 6622 2-s2.0-27244456661 10.1200/JCO.2005.07.024 (Pubitemid 46190255)
2. Geinitz H., Zimmermann F. B., Stoll P., Thamm R., Kaffenberger W., Ansorg K., Keller M., Busch R., Van Beuningen D., Molls M., Fatigue, serum cytokine levels, and blood cell counts during radiotherapy of patients with breast cancer. International Journal of Radiation Oncology Biology Physics 2001 51 3 691 698 2-s2.0-0035501449 10.1016/S0360-3016(01)01657-1
3. Noal S., Levy C., Hardouin A., Rieux C., Heutte N., Ségura C., Collet F., Allouache D., Switsers O., Delcambre C., Delozier T., Henry-Amar M., Joly F., One-year longitudinal study of fatigue, cognitive functions, and quality of life after adjuvant radiotherapy for breast cancer. International Journal of Radiation Oncology Biology Physics 2011 81 3 795 803 2-s2.0-80053470431 10.1016/j.ijrobp.2010.06.037
4. Bower J. E., Ganz P. A., Aziz N., Fahey J. L., Fatigue and proinflammatory cytokine activity in breast cancer survivors. Psychosomatic Medicine 2002 64 4 604 611 2-s2.0-0036071176 (Pubitemid 34791163)
5. Collado-Hidalgo A., Bower J. E., Ganz P. A., Cole S. W., Irwin M. R., Inflammatory biomarkers for persistent fatigue in breast cancer survivors. Clinical Cancer Research 2006 12 9 2759 2766 2-s2.0-33646733403 10.1158/1078-0432.CCR-05-2398
6. Gutstein H. B., The biologic basis of fatigue. Cancer 2001 92 6 1678 1683 2-s2.0-0035883579 (Pubitemid 32939174)
7. Cleeland C. S., Bennett G. J., Dantzer R., Dougherty P. M., Dunn A. J., Meyers C. A., Miller A. H., Payne R., Reuben J. M., Wang X. S., Lee B.-N., Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptoms. Cancer 2003 97 11 2919 2925 2-s2.0-0038182619 10.1002/cncr.11382 (Pubitemid 36605163)
8. Kurzrock R., The role of cytokines in cancer-related fatigue. Cancer 2001 92 6 1684 1688 2-s2.0-0035883484 (Pubitemid 32939175)
9. Greenberg D. B., Gray J. L., Mannix C. M., Eisenthal S., Carey M., Treatment-related fatigue and serum interleukin-1 levels in patients during external beam irradiation for prostate cancer. Journal of Pain and Symptom Management 1993 8 4 196 200 2-s2.0-0027314686 10.1016/0885-3924(93)90127-H (Pubitemid 23148865)
10. Knobf M. T., Sun Y., A longitudinal study of symptoms and self-care activities in women treated with primary radiotherapy for breast cancer. Cancer Nursing 2005 28 3 210 218 2-s2.0-19544385093 (Pubitemid 40734540)
11. Hickok J. T., Morrow G. R., Roscoe J. A., Mustian K., Okunieff P., Occurrence, severity, and longitudinal course of twelve common symptoms in 1129 consecutive patients during radiotherapy for cancer. Journal of Pain and Symptom Management 2005 30 5 433 442 2-s2.0-28344457941 10.1016/j.jpainsymman.2005.04. 012 (Pubitemid 41718963)
12. Cella D., Peterman A., Passik S., Jacobsen P., Breitbart W., Progress toward guidelines for the management of fatigue. Oncology 1998 12 11 A 369 377 2-s2.0-0032199972
13. Yellen S. B., Cella D. F., Webster K., Blendowski C., Kaplan E., Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. Journal of Pain and Symptom Management 1997 13 2 63 74 2-s2.0-0030898261 10.1016/S0885-3924(96) 00274-6 (Pubitemid 27147321)
14. Cella D. F., Tulsky D. S., Gray G., Sarafian B., Linn E., Bonomi A., Silberman M., Yellen S. B., Winicour P., Brannon J., Eckberg K., Lloyd S., Purl S., Blendowski C., Goodman M., Barnicle M., Stewart I., McHale M., Bonomi P., The functional assessment of cancer therapy scale: development and validation of the general measure. Journal of Clinical Oncology 1993 11 3 570 579 2-s2.0-0027407786 (Pubitemid 23071057)
15. Wratten C., Kilmurray J., Nash S., Seldon M., Hamilton C. S., O'Brien P. C., Denham J. W., Fatigue during breast radiotherapy and its relationship to biological factors. International Journal of Radiation Oncology Biology Physics 2004 59 1 160 167 2-s2.0-14644405515 10.1016/j.ijrobp.2003.10.008 (Pubitemid 38501520)
16. Hugh Dunstan R., Sparkes D. L., Macdonald M. M., Roberts T. K., Wratten C., Kumar M. B., Baines S., Denham J. W., Gallagher S. A., Rothkirch T., Altered amino acid homeostasis and the development of fatigue by breast cancer radiotherapy patients: a pilot study. Clinical Biochemistry 2011 44 2-3 208 215 2-s2.0-79151485988 10.1016/j.clinbiochem.2010.10.002
17. Zigmond A. S., Snaith R. P., The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica 1983 67 6 361 370 2-s2.0-0020527558 (Pubitemid 13098606)
18. Cox J. D., Stetz J., Pajak T. F., Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). International Journal of Radiation Oncology Biology Physics 1995 31 5 1341 1346 2-s2.0-0028969271 10.1016/0360-3016(95)00060-C
19. Bünger S., Haug U., Kelly F. M., Klempt-Giessing K., Cartwright A., Posorski N., Dibbelt L., Fitzgerald S. P., Bruch H.-P., Roblick U. J., Von Eggeling F., Brenner H., Habermann J. K., Toward standardized high-throughput serum diagnostics: multiplex-protein array identifies IL-8 and VEGF as serum markers for colon cancer. Journal of Biomolecular Screening 2011 16 9 1018 1026 2-s2.0-80053528075 10.1177/1087057111414894
20. Ferri M., Rossi Del Monte S., Salerno G., Bocchetti T., Angeletti S., Malisan F., Cardelli P., Ziparo V., Torrisi M. R., Visco V., Recovery of immunological homeostasis positively correlates both with early stages of right-colorectal cancer and laparoscopic surgery. PloS ONE 2013 8 9 10.1371/journal.pone.0074455 e74455
21. Davidson R., MacKinnon J. G., Estimation and Inference in Econometrics 1993 Oxford University Press
22. Heckman J. J., Dummy endogenous variables in a simultaneous equation system. Econometrica 1978 46 931 959
23. McCullagh P., Nelder J. A., Generalized Linear Models 1989 Chapman & Hall/CRC
24. Seruga B., Zhang H., Bernstein L. J., Tannock I. F., Cytokines and their relationship to the symptoms and outcome of cancer. Nature Reviews Cancer 2008 8 11 887 899 2-s2.0-54949101585 10.1038/nrc2507
25. Berger A. M., Gerber L. H., Mayer D. K., Cancer-related fatigue: implications for breast cancer survivors. Cancer 2012 118 8 2261 2269 2-s2.0-84859639883 10.1002/cncr.27475
26. Reidunsdatter R. J., Albrektsen G., Hjermstad M. J., Rannestad T., Oldervoll L. M., Lundgren S., One-year course of fatigue after post-operative radiotherapy in Norwegian breast cancer patients-comparison to general population. Acta Oncologica 2013 52 2 239 248
27. Goldstein D., Bennett B., Friedlander M., Davenport T., Hickie I., Lloyd A., Fatigue states after cancer treatment occur both in association with, and independent of, mood disorder: a longitudinal study. BMC Cancer 2006 6, article 240 2-s2.0-33750349720 10.1186/1471-2407-6-240 (Pubitemid 44613105)
28. Brach M. A., Hass R., Sherman M. L., Gunji H., Weichselbaum R., Kufe D., Ionizing radiation induces expression and binding activity of the nuclear factor B. Journal of Clinical Investigation 1991 88 2 691 695 2-s2.0-0025879694
29. Arpin D., Perol D., Blay J.-Y., Falchero L., Claude L., Vuillermoz-Blas S., Martel-Lafay I., Ginestet C., Alberti L., Nosov D., Etienne-Mastroianni B., Cottin V., Perol M., Guerin J.-C., Cordier J.-F., Carrie C., Early variations of circulating interleukin-6 and interleukin-10 levels during thoracic radiotherapy are predictive for radiation pneumonitis. Journal of Clinical Oncology 2005 23 34 8748 8756 2-s2.0-33644845541 10.1200/JCO.2005.01.7145 (Pubitemid 46211520)
30. Meeske K., Smith A. W., Alfano C. M., McGregor B. A., McTiernan A., Baumgartner K. B., Malone K. E., Reeve B. B., Ballard-Barbash R., Bernstein L., Fatigue in breast cancer survivors two to five years post diagnosis: a HEAL study report. Quality of Life Research 2007 16 6 947 960 2-s2.0-34547471500 10.1007/s11136-007-9215-3 (Pubitemid 47174897)
31. Saligan L. N., Kim H. S., A systematic review of the association between immunogenomic markers and cancer-related fatigue. Brain, Behavior and Immunity 2012 26 830 848
32. Janeway C. A. Jr., Medzhitov R., Innate immune recognition. Annual Review of Immunology 2002 20 197 216 2-s2.0-0036212849 10.1146/annurev.immunol.20. 083001.084359 (Pubitemid 34293424)
33. Rock K. L., Lai J.-J., Kono H., Innate and adaptive immune responses to cell death. Immunological Reviews 2011 243 1 191 205 2-s2.0-80052138380 10.1111/j.1600-065X.2011.01040.x
34. Matzinger P., The danger model: a renewed sense of self. Science 2002 296 5566 301 305 2-s2.0-0037066427 10.1126/science.1071059 (Pubitemid 34303674)
35. Greenberg D. B., Sawicka J., Eisenthal S., Ross D., Fatigue syndrome due to localized radiation. Journal of Pain and Symptom Management 1992 7 1 38 45 2-s2.0-0026599718 10.1016/0885-3924(92)90106-R
36. Jereczek-Fossa B. A., Marsiglia H. R., Orecchia R., Radiotherapy-related fatigue. Critical Reviews in Oncology/Hematology 2002 41 3 317 325 2-s2.0-0036514098 10.1016/S1040-8428(01)00143-3 (Pubitemid 34203667)
37. Albuquerque K., Tell D., Lobo P., Millbrandt L., Mathews H. L., Janusek L. W., Impact of partial versus whole breast radiation therapy on fatigue, perceived stress, quality of life and natural killer cell activity in women with breast cancer. BMC Cancer 2012 12 251 10.1186/1471-2407-12-251